Literature DB >> 11036165

Interferon beta-1a downregulates TNFalpha-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway.

G Defazio1, P Livrea, M Giorelli, D Martino, F Roselli, F Ricchiuti, M Trojano.   

Abstract

TNFalpha (100 U/ml, 24 h) upregulated intercellular adhesion molecule 1 (ICAM1) expression on brain microvascular endothelial cell (BMEC) culture. The tyrosine kinase (TK) inhibitor genestein (100 microgram/ml), the protein kinase C (PKC) inhibitor staurosporin (1 nM), and interferon (IF) beta-1a (1000 U/ml) antagonized TNFalpha effect. When an ineffective dose of IFbeta-1a (100 U/ml) was challenged with ineffective doses of either genestein (10 microgram/ml) or staurosporin (0.1 nM), the combination IFbeta-1a-genestein significantly reduced TNFalpha-induced ICAM1 expression whereas IFbeta-1a-staurosporin did not. These findings indicate that a TK- rather than a PKC-dependent mechanism is involved in the modulation of TNFalpha response by IFbeta-1a on BMECs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036165     DOI: 10.1016/s0006-8993(00)02814-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Authors:  Changjun Yang; Kimberly E Hawkins; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-31       Impact factor: 4.249

Review 2.  The mechanism of action of interferon-β in relapsing multiple sclerosis.

Authors:  Bernd C Kieseier
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 3.  Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation.

Authors:  Patric Turowski; Peter Adamson; John Greenwood
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

4.  The Regulation of Immune Responses by DC Derived Type I IFN.

Authors:  Dennis Ng; Jennifer L Gommerman
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

Review 5.  Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.

Authors:  Francesco Roselli; Akila Chandrasekar; Maria C Morganti-Kossmann
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

Review 6.  Anti-inflammatory properties of Type I interferons.

Authors:  Alfons Billiau
Journal:  Antiviral Res       Date:  2006-04-04       Impact factor: 5.970

Review 7.  Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.

Authors:  Anamaria Jurcau; Aurel Simion
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

8.  Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Authors:  Julia Horjus; Tineke van Mourik-Banda; Marco A P Heerings; Marina Hakobjan; Ward De Witte; Dorothea J Heersema; Anne J Jansen; Eva M M Strijbis; Brigit A de Jong; Astrid E J Slettenaar; Esther M P E Zeinstra; Erwin L J Hoogervorst; Barbara Franke; Wiebe Kruijer; Peter J Jongen; Leo J Visser; Geert Poelmans
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.